Search results
Wall Street Lunch: Lilly In Limelight
Seeking Alpha· 1 week agoEli Lilly's tirzepatide reached main goals in two Phase 3 trials for patients with obesity and obstructive sleep apnea. Abbott posts Q1 results beat,...
Eli Lilly's tirzepatide reached main goals in two Phase 3 trials for patients with obesity and obstructive sleep apnea. Abbott posts Q1 results beat,...